HbA1C as a marker of retrograde glycaemic control in diabetes patient with co-existed beta-thalassaemia: A case report and a literature review.

Zoran Gluvic; Milan Obradovic; Milena Lackovic; Vladimir Samardzic; Jelena Tica Jevtic; Magbubah Essack; Vladimir B. Bajic; Esma R Isenovic

doi:10.1111/jcpt.13073

HbA1C as a marker of retrograde glycaemic control in diabetes patient with co-existed beta-thalassaemia: A case report and a literature review.

Zoran Gluvic, Milan Obradovic, Milena Lackovic, Vladimir Samardzic, Jelena Tica Jevtic, Magbubah Essack, Vladimir B. Bajic, Esma R Isenovic

Research output: Contribution to journal › Article › peer-review

4 Scopus citations

Abstract

WHAT IS KNOWN AND OBJECTIVE:The HbA1C marker used in assessing diabetes control quality is not sufficient in diabetes patients with thalassaemia. CASE DESCRIPTION:A male diabetic patient with thalassaemia was hospitalized due to distal neuropathic pain, right toe trophic ulcer, unacceptable five-point glycaemic profile and recommended HbA1C value. After simultaneously initiated insulin therapy and management of ulcer by hyperbaric oxygen, the patient showed improved glycaemic control and ulcer healing, which led to the patient's discharge. WHAT IS NEW AND CONCLUSION:In thalassaemia and haemoglobinopathies, due to discrepancies in the five-point glycaemic profile and HbA1C values, it is necessary to measure HbA1C with a different method or to determine HbA1C and fructosamine simultaneously.

Original language	English (US)
Journal	Journal of Clinical Pharmacy and Therapeutics
DOIs	https://doi.org/10.1111/jcpt.13073
State	Published - Nov 17 2019

Bibliographical note

KAUST Repository Item: Exported on 2020-10-01
Acknowledged KAUST grant number(s): OSR#4129
Acknowledgements: This work is part of the collaboration between the Laboratory of Radiobiology and Molecular Genetics, Vinca Institute of Nuclear Sciences, University of Belgrade, Belgrade, Serbia, Department of Endocrinology and Diabetes, Zemun Clinical Hospital, School of Medicine, University of Belgrade, Belgrade, Serbia, and King Abdullah University of Science and Technology (KAUST), Computational Bioscience Research Center (CBRC), Thuwal, Saudi Arabia. This work has been supported by grants No. 173033 (ERI) from the Ministry of Education, Science and Technological Development, Republic of Serbia and by the KAUST grant OSR#4129 (to ERI and VBB), which also supported ERI,
MO; VBB by the KAUST Base Research Fund (BAS/1/1606-01-01), and VBB and ME by KAUST Office of Sponsored Research (OSR) grant no. FCC/1/1976-17-01.

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1111/jcpt.13073

https://repository.kaust.edu.sa/bitstream/10754/660408/1/Articlefile1.pdf

Cite this

@article{d51296d11fab4a60b9577884fbbffe96,

title = "HbA1C as a marker of retrograde glycaemic control in diabetes patient with co-existed beta-thalassaemia: A case report and a literature review.",

abstract = "WHAT IS KNOWN AND OBJECTIVE:The HbA1C marker used in assessing diabetes control quality is not sufficient in diabetes patients with thalassaemia. CASE DESCRIPTION:A male diabetic patient with thalassaemia was hospitalized due to distal neuropathic pain, right toe trophic ulcer, unacceptable five-point glycaemic profile and recommended HbA1C value. After simultaneously initiated insulin therapy and management of ulcer by hyperbaric oxygen, the patient showed improved glycaemic control and ulcer healing, which led to the patient's discharge. WHAT IS NEW AND CONCLUSION:In thalassaemia and haemoglobinopathies, due to discrepancies in the five-point glycaemic profile and HbA1C values, it is necessary to measure HbA1C with a different method or to determine HbA1C and fructosamine simultaneously.",

author = "Zoran Gluvic and Milan Obradovic and Milena Lackovic and Vladimir Samardzic and {Tica Jevtic}, Jelena and Magbubah Essack and Bajic, {Vladimir B.} and Isenovic, {Esma R}",

note = "KAUST Repository Item: Exported on 2020-10-01 Acknowledged KAUST grant number(s): OSR#4129 Acknowledgements: This work is part of the collaboration between the Laboratory of Radiobiology and Molecular Genetics, Vinca Institute of Nuclear Sciences, University of Belgrade, Belgrade, Serbia, Department of Endocrinology and Diabetes, Zemun Clinical Hospital, School of Medicine, University of Belgrade, Belgrade, Serbia, and King Abdullah University of Science and Technology (KAUST), Computational Bioscience Research Center (CBRC), Thuwal, Saudi Arabia. This work has been supported by grants No. 173033 (ERI) from the Ministry of Education, Science and Technological Development, Republic of Serbia and by the KAUST grant OSR#4129 (to ERI and VBB), which also supported ERI, MO; VBB by the KAUST Base Research Fund (BAS/1/1606-01-01), and VBB and ME by KAUST Office of Sponsored Research (OSR) grant no. FCC/1/1976-17-01.",

year = "2019",

month = nov,

day = "17",

doi = "10.1111/jcpt.13073",

language = "English (US)",

journal = "Journal of Clinical Pharmacy and Therapeutics",

issn = "0269-4727",

publisher = "Wiley-Hindawi",

}

TY - JOUR

T1 - HbA1C as a marker of retrograde glycaemic control in diabetes patient with co-existed beta-thalassaemia: A case report and a literature review.

AU - Gluvic, Zoran

AU - Obradovic, Milan

AU - Lackovic, Milena

AU - Samardzic, Vladimir

AU - Tica Jevtic, Jelena

AU - Essack, Magbubah

AU - Bajic, Vladimir B.

AU - Isenovic, Esma R

N1 - KAUST Repository Item: Exported on 2020-10-01 Acknowledged KAUST grant number(s): OSR#4129 Acknowledgements: This work is part of the collaboration between the Laboratory of Radiobiology and Molecular Genetics, Vinca Institute of Nuclear Sciences, University of Belgrade, Belgrade, Serbia, Department of Endocrinology and Diabetes, Zemun Clinical Hospital, School of Medicine, University of Belgrade, Belgrade, Serbia, and King Abdullah University of Science and Technology (KAUST), Computational Bioscience Research Center (CBRC), Thuwal, Saudi Arabia. This work has been supported by grants No. 173033 (ERI) from the Ministry of Education, Science and Technological Development, Republic of Serbia and by the KAUST grant OSR#4129 (to ERI and VBB), which also supported ERI, MO; VBB by the KAUST Base Research Fund (BAS/1/1606-01-01), and VBB and ME by KAUST Office of Sponsored Research (OSR) grant no. FCC/1/1976-17-01.

PY - 2019/11/17

Y1 - 2019/11/17

N2 - WHAT IS KNOWN AND OBJECTIVE:The HbA1C marker used in assessing diabetes control quality is not sufficient in diabetes patients with thalassaemia. CASE DESCRIPTION:A male diabetic patient with thalassaemia was hospitalized due to distal neuropathic pain, right toe trophic ulcer, unacceptable five-point glycaemic profile and recommended HbA1C value. After simultaneously initiated insulin therapy and management of ulcer by hyperbaric oxygen, the patient showed improved glycaemic control and ulcer healing, which led to the patient's discharge. WHAT IS NEW AND CONCLUSION:In thalassaemia and haemoglobinopathies, due to discrepancies in the five-point glycaemic profile and HbA1C values, it is necessary to measure HbA1C with a different method or to determine HbA1C and fructosamine simultaneously.

AB - WHAT IS KNOWN AND OBJECTIVE:The HbA1C marker used in assessing diabetes control quality is not sufficient in diabetes patients with thalassaemia. CASE DESCRIPTION:A male diabetic patient with thalassaemia was hospitalized due to distal neuropathic pain, right toe trophic ulcer, unacceptable five-point glycaemic profile and recommended HbA1C value. After simultaneously initiated insulin therapy and management of ulcer by hyperbaric oxygen, the patient showed improved glycaemic control and ulcer healing, which led to the patient's discharge. WHAT IS NEW AND CONCLUSION:In thalassaemia and haemoglobinopathies, due to discrepancies in the five-point glycaemic profile and HbA1C values, it is necessary to measure HbA1C with a different method or to determine HbA1C and fructosamine simultaneously.

UR - http://hdl.handle.net/10754/660408

UR - https://onlinelibrary.wiley.com/doi/abs/10.1111/jcpt.13073

UR - http://www.scopus.com/inward/record.url?scp=85075520848&partnerID=8YFLogxK

U2 - 10.1111/jcpt.13073

DO - 10.1111/jcpt.13073

M3 - Article

C2 - 31736110

SN - 0269-4727

JO - Journal of Clinical Pharmacy and Therapeutics

JF - Journal of Clinical Pharmacy and Therapeutics

ER -

HbA1C as a marker of retrograde glycaemic control in diabetes patient with co-existed beta-thalassaemia: A case report and a literature review.

Abstract

Bibliographical note

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this